Temporal Trends in Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer

被引:51
作者
Armstrong, Gregory T. [1 ]
Pan, Zhenyu
Ness, Kirsten K.
Srivastava, Deokumar
Robison, Leslie L.
机构
[1] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; HEALTH-INSURANCE COVERAGE; LONG-TERM SURVIVORS; CARE UTILIZATION; ETHNIC-DIFFERENCES; MEDICAL-CARE; ACCESS; CHEMOTHERAPY; CHILDREN; WHITE;
D O I
10.1200/JCO.2009.24.4608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Five-year survival rates for childhood cancer have improved over the past four decades. However, it is unknown whether changes in primary cancer therapy have improved rates of long-term (> 5 years from diagnosis) durable remissions and reduced treatment-related deaths. We investigated changes in patterns of late mortality over time and cause-specific attribution of late-mortality among 5-year survivors. Patients and Methods Using data from the Surveillance, Epidemiology and End Results (SEER) population-based registry, we assessed all-cause and cause-specific (recurrence/progression of primary disease, external cause, and nonrecurrence/nonexternal cause) late mortality during four consecutive time periods from 1974 through 2000 among 26,643 5-year survivors of childhood cancer. Results All-cause late mortality improved during more recent eras, dropping from 7.1% (95% CI, 6.4% to 7.8%) among children diagnosed during 1974 to 1980 to 3.9% (95% CI, 3.3% to 4.4%) among children diagnosed during 1995 to 2000 (P < .001), largely because of reduced mortality from recurrence or progression. While there was no significant reduction in mortality attributable to other health conditions (including treatment-related health conditions), analysis controlling for demographic characteristics identified a trend toward reduced risk during more recent eras (P = .007). Disparity by race/ethnicity was identified, with higher mortality among non-Hispanic blacks than among non-Hispanic whites for all-cause and nonrecurrence/nonexternal -cause late mortality. Conclusion While overall patterns of mortality from other health conditions do not differ over time, adjustment for demographic characteristics provides evidence that risk of treatment-related mortality may be lower in more recent eras. Disparities in health care utilization among survivors should be explored.
引用
收藏
页码:1224 / 1231
页数:8
相关论文
共 34 条
[1]   Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study [J].
Armstrong, Gregory T. ;
Liu, Qi ;
Yasui, Yutaka ;
Neglia, Joseph P. ;
Leisenring, Wendy ;
Robison, Leslie L. ;
Mertens, Ann C. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (14) :2328-2338
[2]  
AUR RJA, 1972, CANCER, V29, P381, DOI 10.1002/1097-0142(197202)29:2<381::AID-CNCR2820290219>3.0.CO
[3]  
2-P
[4]   Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia [J].
Bhatia, S .
CURRENT OPINION IN PEDIATRICS, 2004, 16 (01) :9-14
[5]  
Breslow N.E., 1987, STAT METHODS CANC RE, VII, P82
[6]   Going bare: Trends in health insurance coverage, 1989 through 1996 [J].
Carrasquillo, O ;
Himmelstein, DU ;
Woolhandler, S ;
Bor, DH .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1999, 89 (01) :36-42
[7]   Trends in health insurance coverage, 1989-1997 [J].
Carrasquillo, O ;
Himmelstein, DU ;
Woolhandler, S ;
Bor, DH .
INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1999, 29 (03) :467-483
[8]   Minority adult survivors of childhood cancer: A comparison of long-term outcomes, health care utilization, and health-related behaviors from the Childhood Cancer Survivor Study [J].
Castellino, SM ;
Casillas, J ;
Hudson, MM ;
Mertens, AC ;
Whitton, J ;
Brooks, SL ;
Zeltzer, LK ;
Ablin, A ;
Castleberry, R ;
Hobbie, W ;
Kaste, S ;
Robison, LL ;
Oeffinger, KC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6499-6507
[9]  
CORNELIUS LJ, 1993, J NATL MED ASSOC, V85, P281
[10]   Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia [J].
Davies, SM ;
Robison, LL ;
Buckley, JD ;
Tjoa, T ;
Woods, WG ;
Radloff, GA ;
Ross, JA ;
Perentesis, JP .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1279-1287